Neuroone Medical Technologies Corp reports results for the quarter ended in March - Earnings Summary

Neuroone Medical Technologies

13/05/2022 17:43

* Neuroone Medical Technologies Corp  NMTC.OQ  reported a
quarterly adjusted loss of 19 cents​​ per share for the quarter
ended in March. The mean expectation of two analysts for the
quarter was for a loss of 20 cents per share.
    * Revenue was $36.58 thousand​;  analysts expected zero. 
    * Neuroone Medical Technologies Corp's reported EPS for the
quarter was a loss of 19 cents​.
    * The mean earnings estimate of analysts had fallen by
about 122.2% in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Neuroone Medical Technologies Corp shares had fallen
by 51.0%
this quarter and lost 72.2% so far this year.
    * The company reported a quarterly loss of $3.06 million.
    * Wall Street's median 12-month price target for Neuroone
Medical
Technologies Corp is $2.63 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 13 at 04:43 p.m.  ​All
figures in US dollars unless otherwise stated